Reach Us +44-1647-403003
Dannis G van Vuurden | OMICS International
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Dannis G van Vuurden

Dannis G van Vuurden
Department of Pediatric Oncology/ Hematology
VU University Medical Center
Amsterdam, Netherlands
Tel: +31-20-444-2420


Dannis van Vuurden, MD, is working as a pediatric oncologist / hematologist in VU University Medical Center (VUmc) since 2008. His specific focus, both in the clinic as in translational research, is on pediatric high-grade brain tumors, with an emphasis on pediatric high-grade glioma and DIPG. He obtained his PhD in 2014 at the VU University Amsterdam, with his thesis entitled: 'Innovative treatment targets in pediatric high-grade brain tumors', studying new targets in vitro for potential translation to the clinic. After his PhD, he combines clinical work with translational research, leading translational pediatric neuro-oncology projects, translating new therapies from the lab to the clinic. Together with the Neuro-Oncology Research Group of the VUmc Cancer Center Amsterdam, the department of clinical pharmacology and pharmacy and department of radiology & nuclear medicine of VUmc he is developing molecular imaging studies, to increase knowledge on drug delivery in pediatric brain tumor patients, by using novel agents coupled to radio-isotopes, imaged by PET. Furthermore, he is leading early phase clinical trials, such as a study of convection-enhanced intra-tumoral delivery of BiCNU in patients with progressive DIPG. He is an active member of the Novel Therapeutics Research Committee of the Dutch Childhood Oncology Group (DCOG) As chair of the DIPG Network of the International Society of Pediatric Oncology Europe (SIOPe) he has created a European DIPG Registry, which allows registration of all European DIPG patients for research and future collaborative international trials in DIPG.

Research Interest

Pediatric neuro-oncology Diffuse intrinsic pontine glioma


Cytotoxicity and Radiosensitization of High Grade Glioma Cells by CI-1033, an Irreversible Pan-Erbb Inhibitor

Dannis G van Vuurden, Shruti Shukla, Laurine E Wedekind, Gitta K. Kuipers, David P Noske, W Peter Vandertop, M Vincent M Lafleur, Ben J Slotman, Esther Hulleman, Gertjan JL Kaspers and Jacqueline Cloos

Research Article: J Cancer Sci Ther/Vol.5.7 249-255 (2013)

DOI: 10.4172/1948-5956.1000213

Global Speakers in the subject

Global Experts in the subject